v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Cash flows from operating activities    
Net loss $ (135,020) $ (101,992)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 6,769 5,599
Stock-based compensation 25,421 25,649
Net accretion of discount on marketable securities (7,795) (3,453)
Loss on disposal of property and equipment 0 544
Amortization of operating lease right-of-use assets 5,356 4,298
Other 286 0
Changes in operating assets and liabilities:    
Accounts receivable 0 (2,000)
Prepaid expenses and other assets 767 2,556
Accounts payable (2,376) (3,036)
Deferred revenue (15,265) (31,327)
Operating lease liabilities (4,768) (4,940)
Accrued expenses and other current liabilities 2,792 48
Net cash used in operating activities (123,833) (108,054)
Cash flows from investing activities    
Purchases of marketable securities (409,738) (157,941)
Maturities of marketable securities 300,010 246,431
Purchases of property and equipment (7,168) (5,816)
Net cash (used in) provided by investing activities (116,896) 82,674
Cash flows from financing activities    
Proceeds from issuances of common stock and pre-funded warrants in equity financing, net of issuance costs 188,732 0
Proceeds from issuances of common stock in "at the market" financing, net of issuance costs 90,691 0
Proceeds from exercise of stock options and pre-funded warrants 3,606 981
Proceeds from issuance under employee stock purchase plan 2,132 2,229
Repurchase of unvested early exercised stock options (15) 0
Net cash provided by financing activities 285,146 3,210
Net increase (decrease) in cash, cash equivalents and restricted cash 44,417 (22,170)
Cash, cash equivalents and restricted cash at beginning of period 55,528 65,375
Cash, cash equivalents and restricted cash at end of period 99,945 43,205
Supplemental disclosures of non-cash investing and financing activities:    
Additions to property and equipment included in accounts payable and accrued expenses and other current liabilities 483 1,054
Right-of-use assets recognized in exchange for lease obligations 1,297 0
Capitalized stock-based compensation related to internal-use software development 11 72
Deferred issuance costs included in accrued expenses and other current liabilities 156 0
Deferred issuance costs recognized related to the "at the market" financing 242 0
Vesting of early exercised stock options 33 91
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 99,044 42,304
Restricted cash 901 901
Total cash, cash equivalents and restricted cash $ 99,945 $ 43,205